abagovomab 46
abciximab 40
abituzumab 31
abrilumab 30
actoxumab 32
adalimumab 21
aducanumab 18
afasevikumab 21
alacizumab_pegol 15
alemtuzumab 43
alirocumab 26
amatuximab 58
andecaliximab 37
anifrolumab 31
anrukinzumab 22
aprutumab 21
aprutumab_ixadotin 21
arcitumomab 29
ascrinvacumab 23
atezolizumab 16
atinumab 24
avelumab 21
basiliximab 51
bavituximab 52
begelomab 40
benralizumab 39
bevacizumab_beta 25
bezlotoxumab 32
bimagrumab 32
bleselumab 33
blinatumomab 50
blosozumab 35
bococizumab 31
brazikumab 23
brentuximab_vedotin 46
briakinumab 21
brodalumab 29
brolucizumab 30
brontictuzumab 37
burosumab 31
cabiralizumab 38
camrelizumab 16
canakinumab 25
cantuzumab_ravtansin 60
carlumab 28
carotuximab 35
cergutuzumab_amunaleukin2 39
cergutuzumab_amunaleukin 39
certolizumab_pegol 28
cetiximab 55
citatuzumab_bogatox 32
cixutumumab 45
clivatuzumab_tetraxetan 33
codrituzumab 39
conatumumab 27
concizumab 33
crenezumab 24
crizanlizumab 35
crotedumab 26
dacetuzumab 27
daclizumab 27
dalotuzumab 49
dapirolizumab_pegol 29
daratumumab 19
dectrekumab 14
demcizumab 40
denosumab 11
depatuxizumab 38
depatuxizumab_mafodotin 38
dezamizumab 34
dinutuximab 49
diridavumab 37
domagrozumab 20
drozitumab 27
duligotuzumab 21
durvalumab 18
dusigitumab 36
efalizumab 38
efungumab 37
eldelumab 23
elezanumab 37
elgemtumab 15
elotuzumab 23
emactuzumab 32
emapalumab 32
emibetuzumab 28
enavatuzumab 29
enfortumab_vedotin 16
enoblituzumab 23
enokizumab 34
enoticumab 27
ensituximab 49
eptinezumab 21
erenumab 30
etaracizumab 18
etrolizumab 24
evinacumab 26
evolocumab 33
farletuzumab 14
fasinumab 33
fezakinumab 38
fibatuzumab 26
ficlatuzumab 35
firivumab 43
flanvotumab 32
fletikumab 39
foralumab 21
foravirumab 19
fremanezumab 36
fresolimumab 30
fulranumab 23
futuximab 42
galcanezumab 28
ganitumab 42
gantenerumab 18
gemetuzumab 45
gemtuzumab2 39
gemtuzumab 38
gevokizumab 37
girentuximab 35
glembatumumab 36
glembatumumab_vedotin 36
guselkumab 31
ibalizumab 38
ibritumomab 53
icrucumab 20
idarucizumab 52
ifabotuzumab 26
imalumab 19
imgatuzumab 32
inclacumab 27
indatuximab_ravtansin 43
indusatumab 31
inebilizumab 30
intetumumab 21
iodine_girentuximab 33
ipilimumab 12
iratumumab 29
isatuximab 45
itolizumab 30
ixekizumab 43
labetuzumab_govitecan 29
lambrolizumab 37
lampalizumab 31
lanadelumab 21
landogrozumab 22
laprituximab 37
lebrikizumab 48
lendalizumab 36
lenzilumab 30
lifastuzumab_vedotin 28
ligelizumab 34
lilotomab 48
lirilumab 38
lodelcizumab 31
lokivetmab 28
lorvotuzumab_mertansin 29
lucatumumab 35
lumretuzumab 30
lupartumab 20
lutikizumab 21
margetuximab 40
milatuzumab 49
mirvetuximab 48
mirvetuximab_soravtansin 48
modotuximab 57
mogamulizumab 33
monalizumab 34
motavizumab 44
moxetumomab_pasudotox 34
namilumab 37
naratuximab 43
naratuximab_emtansin 43
narnatumab 23
navicixizumab2 34
navicixizumab 41
navivumab 42
necitumumab 28
nemolizumab 38
nesvacumab 20
nivolumab 22
obiltoxaximab 33
obinutuzumab 43
ocaratuzumab 36
ofatumumab 25
olaratumab 36
olokizumab 27
omalizumab 24
onartuzumab 26
ontuxizumab 43
opicinumab 19
orticumab 18
otelixizumab 41
oxelumab 15
ozanezumab 44
pamrevlumab 15
panobacumab 33
parsatuzumab 33
pasotuxizumab 23
pateclizumab 24
patritumab 37
pembrolizumab 37
perakizumab 27
pidilizumab 29
pinatuzumab_vedotin 22
plozalizumab 34
pogalizumab 35
polatuzumab_vedotin 25
ponezumab 47
prezalumab 18
pritoxaximab 58
quilizumab 22
racotumomab 41
radretumab 20
ralpancizumab 33
ramucirumab 18
ranevetmab 35
ranibizumab 28
refanezumab 31
remtolumab 21
rilotumumab 33
rinucumab 36
risankizumab 41
rituximab 38
rivabazumab 26
robatumumab 22
roledumab 36
romosozumab 33
rontalizumab 29
rosmantuzumab 33
rozanolixizumab 27
sacituzumab 37
sacituzumab_govitecan 37
samalizumab 36
sapelizumab 33
sarilumab 20
secukinumab 22
seribantumab 20
setoxaximab 55
sifalimumab 27
siltuximab 36
simtuzumab 40
sirukumab 18
solanezumab 29
solitomab 41
stamulumab 35
suptavumab 31
suvizumab 26
tabalumab 33
tadocizumab 29
tamtuvetmab 39
tanezumab 35
tarextumab 15
tavolixizumab 30
telisotuzumab 42
teplizumab 28
tesidolumab 41
tezepelumab 37
tigatuzumab 20
tildrakizumab 30
timolumab 22
tisotumab 17
tosatoxumab 48
tositumomab 50
tralokinumab 46
trastuzumab 25
tregalizumab 28
trevogrumab 18
ublituximab 42
urelumab 36
ustekinumab 35
utomilumab 41
vadastuximab 38
vadastuximab_talirin 38
vandortuzumab_vedotin 25
vantictumab 30
vanucizumab2 25
vanucizumab 51
varlilumab 20
vatelizumab 39
vedolizumab 41
veltuzumab 34
vesencumab 15
vorsetuzumab 34
vorsetuzumab_mafodotin 34
vunakizumab 44
xentuzumab 23
zatuximab 57
